Contract Pharma
Contract Pharma, headquartered in the United States, is a leading publication in the pharmaceutical contract services industry. Founded in 2000, the company has established itself as a vital resource for professionals involved in contract manufacturing, packaging, and development services. With a focus on the North American market, Contract Pharma provides in-depth insights into industry trends, regulatory updates, and best practices. The publication covers a wide range of topics, including drug formulation, clinical trials, and supply chain management, making it an essential tool for stakeholders in the pharmaceutical sector. Notable achievements include its comprehensive annual Contract Pharma Awards, recognising excellence in contract services. With a commitment to delivering high-quality content, Contract Pharma remains a trusted source for industry professionals seeking to navigate the complexities of pharmaceutical outsourcing.
DitchCarbon Score
How does Contract Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Contract Pharma's score of 3 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Contract Pharma's reported carbon emissions
Contract Pharma, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Contract Pharma may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce greenhouse gas emissions across all scopes. As the industry evolves, it is likely that Contract Pharma will develop and disclose its climate strategies and emissions data in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Contract Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
